| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |